Boric Acid

Boric Acid

SCHEMBL28009709

CC(C)(O)C(C)(C)O.Cc1cc(C)[nH]n1.OB(O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.38
DAO P14920 1/20 0.38
GAA P10253 2/20 0.37
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.33
ALPL P05186 1/20 0.33
MAPT P10636 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HDAC3 O15379 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC7 Q8WUI4 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC10 Q969S8 1/20 0.30
HDAC11 Q96DB2 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
HDAC9 Q9UKV0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Boric Acid SCHEMBL30492946 0.89 HCAR2 (0.45) HCAR2DAOGAALMNAL3MBTL1
Boric Acid SCHEMBL17848565 0.89 HCAR2 (0.45) HCAR2DAOGAALMNAL3MBTL1
SCHEMBL1503 0.80
SCHEMBL30404482 0.78
SCHEMBL30802139 0.78
SCHEMBL29150915 0.78
SCHEMBL28959328 0.78 HCAR2 (0.44) HCAR2DAOGAALMNAL3MBTL1
Potassium SCHEMBL30471622 0.78
SCHEMBL28852463 0.78 HCAR2 (0.44) HCAR2DAOGAALMNAL3MBTL1
SCHEMBL10661053 0.75 HCAR2 (0.43) HCAR2DAOGAALMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104540828-B As the substituted pyrazoloquinazolone and pyrrolo- quinazolinone of the allosteric modulators of II group metabotropic glutamate receptors 多曼治疗学公司 2017-06-13 CN disclosed
CN-104540828-A Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptors DOMAIN THERAPEUTICS 2015-04-22 CN disclosed